Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited or not administered directly by the JCCC.

Listings are generally updated as a batch on a quarterly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

**IMPORTANT** The 21st Century Cures Act was signed into law in December 2016, and authorizes $1.8 billion over seven years to fund the Beau Biden Cancer Moonshot Initiative. The National Cancer Institute has released numerous funding opportunity announcements, and additional funding initiatives are anticipated. You are encouraged to visit their website for a complete and current list of funding opportunities that may be available to you.


Posted May 20, 2021

2021 Gabrielle's Angel Foundation Conventional and Integrative Grants

Deadline: proposal to the Cancer Center due Friday, June 11, 2021 / full application due Friday, August 27, 2021

How to apply: Please email one or two paragraphs on your proposal and biosketch to Nancy Presseau at npresseau@mednet.ucla.edu

About the award: Gabrielle’s Angel Foundation for Cancer Research is soliciting grant applications to fund innovative and insightful medical research. Gabrielle’s Angel has focused on supporting promising junior investigators conducting scientific research that can be applied to improving the treatment of patients with these diseases. Gabrielle’s Angel has invited the JCCC to nominate only one application per category/per institution for their Conventional and Integrative grants.

Conventional grants are conventional or mainstream projects. Integrative grants are integrative research projects that explore evidence-based complementary interventions such as acupuncture, nutrition, meditation, yoga, etc. Also supports clinical trials and/or pre-clinical research that addresses reducing patients’ physical and emotional distress during or after cancer therapy.

The award for each grant is $75,000 a year for 3 years. Overhead/indirect costs may not exceed 10% of the total grant award.